Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-01

FDA Approved: BENZONATATE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for BENZONATATE submitted by Amneal Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benzonatate (BENZONATATE)

Snippet

SUPPL AP for BENZONATATE (BENZONATATE)